A 2012 meningitis outbreak, which killed more than 100 people and ultimately was traced back to mold-tainted steroids at a compounding facility in Massachusetts, spurred health systems across the United States to seek a safe, consistent and affordable source of compounded drugs for their patients.
One cooperative of New England–area hospitals, New England Life Care (NELC), eventually opted to create its own 503B sterile compounding facility: Advanced Compounding Solutions